Cargando…

In Vitro Antimicrobial Evaluation, Single-Point Resistance Study, and Radiosterilization of Novel Pyrazole Incorporating Thiazol-4-one/Thiophene Derivatives as Dual DNA Gyrase and DHFR Inhibitors against MDR Pathogens

[Image: see text] A series of thiazol-4-one/thiophene-bearing pyrazole derivatives as pharmacologically attractive cores were initially synthesized using a hybridization approach. All structures were confirmed using spectra analysis techniques (IR, (1)H NMR, and (13)C NMR). In vitro antimicrobial ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali Mohamed, Hazem, Ammar, Yousry A., A.M. Elhagali, Gameel, A. Eyada, Hassan, S. Aboul-Magd, Dina, Ragab, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851638/
https://www.ncbi.nlm.nih.gov/pubmed/35187315
http://dx.doi.org/10.1021/acsomega.1c05801
_version_ 1784652862607851520
author Ali Mohamed, Hazem
Ammar, Yousry A.
A.M. Elhagali, Gameel
A. Eyada, Hassan
S. Aboul-Magd, Dina
Ragab, Ahmed
author_facet Ali Mohamed, Hazem
Ammar, Yousry A.
A.M. Elhagali, Gameel
A. Eyada, Hassan
S. Aboul-Magd, Dina
Ragab, Ahmed
author_sort Ali Mohamed, Hazem
collection PubMed
description [Image: see text] A series of thiazol-4-one/thiophene-bearing pyrazole derivatives as pharmacologically attractive cores were initially synthesized using a hybridization approach. All structures were confirmed using spectra analysis techniques (IR, (1)H NMR, and (13)C NMR). In vitro antimicrobial activities, including the minimum inhibitory concentration (MIC), minimum bactericidal/fungicidal concentration (MBC/MFC), and time-kill assay, were evaluated for the most active derivatives 4a, 5a, 7b, 10, and 13. These derivatives were significantly active against the tested pathogens, with compound 7b as the most active derivative (MIC values range from 0.22 to 0.25 μg/mL). In the MBC and MFC, the active target pyrazole derivatives showed -cidal activities toward the pathogenic isolates. Further, the inhibition of biofilm formation of Staphylococcus aureus and Staphylococcus epidermidis was also carried out. Additionally, these derivatives displayed significant antibiofilm potential with a superior % reduction in the biofilm formation compared with Ciprofloxacin. The target derivatives behaved synergistically with Ciprofloxacin and Ketoconazole, reducing their MICs. Hemolytic results revealed that these derivatives were nontoxic with a significantly low hemolytic activity (%lysis range from 3.23 to 15.22%) compared with Triton X-100 and showed noncytotoxicity activity with IC(50) values > 60 μM. In addition, these derivatives proved to be active DNA gyrase and DHFR inhibitors with IC(50) ranging between 12.27–31.64 and 0.52–2.67 μM, respectively. Furthermore, compound 7b showed bactericidal activity at different concentrations in the time-kill assay. Moreover, a gamma radiation dose of 10.0 kGy was efficient for sterilizing compound 7b and enhancing its antimicrobial activity. Finally, molecular docking simulation of the most promising derivatives exhibited good binding energy with different interactions.
format Online
Article
Text
id pubmed-8851638
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-88516382022-02-18 In Vitro Antimicrobial Evaluation, Single-Point Resistance Study, and Radiosterilization of Novel Pyrazole Incorporating Thiazol-4-one/Thiophene Derivatives as Dual DNA Gyrase and DHFR Inhibitors against MDR Pathogens Ali Mohamed, Hazem Ammar, Yousry A. A.M. Elhagali, Gameel A. Eyada, Hassan S. Aboul-Magd, Dina Ragab, Ahmed ACS Omega [Image: see text] A series of thiazol-4-one/thiophene-bearing pyrazole derivatives as pharmacologically attractive cores were initially synthesized using a hybridization approach. All structures were confirmed using spectra analysis techniques (IR, (1)H NMR, and (13)C NMR). In vitro antimicrobial activities, including the minimum inhibitory concentration (MIC), minimum bactericidal/fungicidal concentration (MBC/MFC), and time-kill assay, were evaluated for the most active derivatives 4a, 5a, 7b, 10, and 13. These derivatives were significantly active against the tested pathogens, with compound 7b as the most active derivative (MIC values range from 0.22 to 0.25 μg/mL). In the MBC and MFC, the active target pyrazole derivatives showed -cidal activities toward the pathogenic isolates. Further, the inhibition of biofilm formation of Staphylococcus aureus and Staphylococcus epidermidis was also carried out. Additionally, these derivatives displayed significant antibiofilm potential with a superior % reduction in the biofilm formation compared with Ciprofloxacin. The target derivatives behaved synergistically with Ciprofloxacin and Ketoconazole, reducing their MICs. Hemolytic results revealed that these derivatives were nontoxic with a significantly low hemolytic activity (%lysis range from 3.23 to 15.22%) compared with Triton X-100 and showed noncytotoxicity activity with IC(50) values > 60 μM. In addition, these derivatives proved to be active DNA gyrase and DHFR inhibitors with IC(50) ranging between 12.27–31.64 and 0.52–2.67 μM, respectively. Furthermore, compound 7b showed bactericidal activity at different concentrations in the time-kill assay. Moreover, a gamma radiation dose of 10.0 kGy was efficient for sterilizing compound 7b and enhancing its antimicrobial activity. Finally, molecular docking simulation of the most promising derivatives exhibited good binding energy with different interactions. American Chemical Society 2022-02-03 /pmc/articles/PMC8851638/ /pubmed/35187315 http://dx.doi.org/10.1021/acsomega.1c05801 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Ali Mohamed, Hazem
Ammar, Yousry A.
A.M. Elhagali, Gameel
A. Eyada, Hassan
S. Aboul-Magd, Dina
Ragab, Ahmed
In Vitro Antimicrobial Evaluation, Single-Point Resistance Study, and Radiosterilization of Novel Pyrazole Incorporating Thiazol-4-one/Thiophene Derivatives as Dual DNA Gyrase and DHFR Inhibitors against MDR Pathogens
title In Vitro Antimicrobial Evaluation, Single-Point Resistance Study, and Radiosterilization of Novel Pyrazole Incorporating Thiazol-4-one/Thiophene Derivatives as Dual DNA Gyrase and DHFR Inhibitors against MDR Pathogens
title_full In Vitro Antimicrobial Evaluation, Single-Point Resistance Study, and Radiosterilization of Novel Pyrazole Incorporating Thiazol-4-one/Thiophene Derivatives as Dual DNA Gyrase and DHFR Inhibitors against MDR Pathogens
title_fullStr In Vitro Antimicrobial Evaluation, Single-Point Resistance Study, and Radiosterilization of Novel Pyrazole Incorporating Thiazol-4-one/Thiophene Derivatives as Dual DNA Gyrase and DHFR Inhibitors against MDR Pathogens
title_full_unstemmed In Vitro Antimicrobial Evaluation, Single-Point Resistance Study, and Radiosterilization of Novel Pyrazole Incorporating Thiazol-4-one/Thiophene Derivatives as Dual DNA Gyrase and DHFR Inhibitors against MDR Pathogens
title_short In Vitro Antimicrobial Evaluation, Single-Point Resistance Study, and Radiosterilization of Novel Pyrazole Incorporating Thiazol-4-one/Thiophene Derivatives as Dual DNA Gyrase and DHFR Inhibitors against MDR Pathogens
title_sort in vitro antimicrobial evaluation, single-point resistance study, and radiosterilization of novel pyrazole incorporating thiazol-4-one/thiophene derivatives as dual dna gyrase and dhfr inhibitors against mdr pathogens
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851638/
https://www.ncbi.nlm.nih.gov/pubmed/35187315
http://dx.doi.org/10.1021/acsomega.1c05801
work_keys_str_mv AT alimohamedhazem invitroantimicrobialevaluationsinglepointresistancestudyandradiosterilizationofnovelpyrazoleincorporatingthiazol4onethiophenederivativesasdualdnagyraseanddhfrinhibitorsagainstmdrpathogens
AT ammaryousrya invitroantimicrobialevaluationsinglepointresistancestudyandradiosterilizationofnovelpyrazoleincorporatingthiazol4onethiophenederivativesasdualdnagyraseanddhfrinhibitorsagainstmdrpathogens
AT amelhagaligameel invitroantimicrobialevaluationsinglepointresistancestudyandradiosterilizationofnovelpyrazoleincorporatingthiazol4onethiophenederivativesasdualdnagyraseanddhfrinhibitorsagainstmdrpathogens
AT aeyadahassan invitroantimicrobialevaluationsinglepointresistancestudyandradiosterilizationofnovelpyrazoleincorporatingthiazol4onethiophenederivativesasdualdnagyraseanddhfrinhibitorsagainstmdrpathogens
AT saboulmagddina invitroantimicrobialevaluationsinglepointresistancestudyandradiosterilizationofnovelpyrazoleincorporatingthiazol4onethiophenederivativesasdualdnagyraseanddhfrinhibitorsagainstmdrpathogens
AT ragabahmed invitroantimicrobialevaluationsinglepointresistancestudyandradiosterilizationofnovelpyrazoleincorporatingthiazol4onethiophenederivativesasdualdnagyraseanddhfrinhibitorsagainstmdrpathogens